align technology inc. - ALGN

ALGN

Close Chg Chg %
180.27 -2.41 -1.34%

Open Market

177.86

-2.41 (1.34%)

Volume: 393.67K

Last Updated:

Mar 26, 2026, 2:52 PM EDT

Company Overview: align technology inc. - ALGN

ALGN Key Data

Open

$177.66

Day Range

177.08 - 182.97

52 Week Range

122.00 - 208.31

Market Cap

$12.85B

Shares Outstanding

71.28M

Public Float

66.53M

Beta

1.79

Rev. Per Employee

N/A

P/E Ratio

31.89

EPS

$5.66

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.45M

 

ALGN Performance

1 Week
 
4.09%
 
1 Month
 
-5.17%
 
3 Months
 
13.83%
 
1 Year
 
13.23%
 
5 Years
 
-65.88%
 

ALGN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 17
Full Ratings ➔

About align technology inc. - ALGN

Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad’s CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

ALGN At a Glance

Align Technology, Inc.
410 North Scottsdale Road
Tempe, Arizona 85288
Phone 1-602-742-2000 Revenue 4.03B
Industry Medical Specialties Net Income 410.35M
Sector Health Technology 2025 Sales Growth 0.899%
Fiscal Year-end 12 / 2026 Employees 20,290
View SEC Filings

ALGN Valuation

P/E Current 31.888
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 27.622
Price to Sales Ratio 2.809
Price to Book Ratio 2.752
Price to Cash Flow Ratio 19.11
Enterprise Value to EBITDA 12.161
Enterprise Value to Sales 2.566
Total Debt to Enterprise Value 0.011

ALGN Efficiency

Revenue/Employee 198,864.662
Income Per Employee 20,224.298
Receivables Turnover 3.486
Total Asset Turnover 0.648

ALGN Liquidity

Current Ratio 1.363
Quick Ratio 1.245
Cash Ratio 0.57

ALGN Profitability

Gross Margin 69.804
Operating Margin 17.122
Pretax Margin 14.505
Net Margin 10.17
Return on Assets 6.593
Return on Equity 10.387
Return on Total Capital 9.856
Return on Invested Capital 10.167

ALGN Capital Structure

Total Debt to Total Equity 2.826
Total Debt to Total Capital 2.749
Total Debt to Total Assets 1.836
Long-Term Debt to Equity 2.038
Long-Term Debt to Total Capital 1.982
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Align Technology Inc. - ALGN

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
3.73B 3.86B 4.00B 4.03B
Sales Growth
-5.51% +3.42% +3.54% +0.90%
Cost of Goods Sold (COGS) incl D&A
1.08B 1.14B 1.18B 1.22B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
156.32M 142.40M 145.03M 160.54M
Depreciation
140.32M 126.00M 126.13M 141.74M
Amortization of Intangibles
16.00M 16.40M 18.90M 18.80M
COGS Growth
+8.55% +4.86% +3.58% +3.44%
Gross Income
2.65B 2.73B 2.82B 2.82B
Gross Income Growth
-10.27% +2.83% +3.52% -0.16%
Gross Profit Margin
+70.96% +70.56% +70.55% +69.80%
2022 2023 2024 2025 5-year trend
SG&A Expense
1.98B 2.05B 2.13B 2.13B
Research & Development
305.26M 346.83M 364.20M 369.91M
Other SG&A
1.67B 1.70B 1.76B 1.76B
SGA Growth
+1.06% +3.56% +3.76% -0.08%
Other Operating Expense
- 16.43M 18.25M 21.96M
Unusual Expense
11.45M 13.32M 28.94M 179.30M
EBIT after Unusual Expense
642.60M 643.34M 642.83M 511.55M
Non Operating Income/Expense
(43.54M) (2.13M) (33.87M) 73.73M
Non-Operating Interest Income
5.37M 17.26M 20.22M 16.05M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
599.06M 641.20M 608.96M 585.29M
Pretax Income Growth
-40.83% +7.04% -5.03% -3.89%
Pretax Margin
+16.04% +16.60% +15.23% +14.51%
Income Tax
237.48M 196.15M 187.60M 174.94M
Income Tax - Current - Domestic
222.67M 162.87M 108.73M 66.94M
Income Tax - Current - Foreign
56.54M 51.31M 56.65M 74.69M
Income Tax - Deferred - Domestic
(67.84M) (19.96M) 4.96M 28.15M
Income Tax - Deferred - Foreign
26.12M 1.94M 17.25M 5.16M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
361.57M 445.05M 421.36M 410.35M
Minority Interest Expense
- - - -
-
Net Income
361.57M 445.05M 421.36M 410.35M
Net Income Growth
-53.17% +23.09% -5.32% -2.61%
Net Margin Growth
+9.68% +11.52% +10.54% +10.17%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
361.57M 445.05M 421.36M 410.35M
Preferred Dividends
- - - -
-
Net Income Available to Common
361.57M 445.05M 421.36M 410.35M
EPS (Basic)
4.6243 5.8233 5.6274 5.6567
EPS (Basic) Growth
-52.73% +25.93% -3.36% +0.52%
Basic Shares Outstanding
78.19M 76.43M 74.88M 72.54M
EPS (Diluted)
4.6107 5.8125 5.6187 5.6532
EPS (Diluted) Growth
-52.42% +26.07% -3.33% +0.61%
Diluted Shares Outstanding
78.42M 76.57M 74.99M 72.59M
EBITDA
810.37M 799.05M 816.80M 851.39M
EBITDA Growth
-27.12% -1.40% +2.22% +4.23%
EBITDA Margin
+21.70% +20.69% +20.42% +21.10%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 200.154
Number of Ratings 17 Current Quarters Estimate 2.292
FY Report Date 03 / 2026 Current Year's Estimate 11.311
Last Quarter’s Earnings 3.29 Median PE on CY Estimate N/A
Year Ago Earnings 10.51 Next Fiscal Year Estimate 12.303
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 13 13 15 14
Mean Estimate 2.29 2.77 11.31 12.30
High Estimates 2.50 2.95 12.05 13.19
Low Estimate 2.23 2.67 11.11 11.70
Coefficient of Variance 3.50 3.41 2.09 3.11

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 7 8 9
OVERWEIGHT 3 1 2
HOLD 5 7 7
UNDERWEIGHT 2 2 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Align Technology Inc. in the News